The Commonwealth of Pennsylvania is set to receive as much as $212 million of a $7.4 billion settlement from Purdue Pharma ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...

A settlement reached with the Sackler family and Purdue Pharma will bring over $27 million to the First State, roughly half ...

Family and company to make payment to group of US states and other parties to settle long-running litigation over OxyContin’s ...

Sackler family, who owned pharmaceutical company Purdue Pharma, will no longer be in control of the company or permitted to sell opioids if the new settlement plan is approved ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis, ...

The agreement, announced Thursday, would require the Sackler family to pay $6.5 billion over the next 15 years and an additional nearly $900 million from Purdue Pharma following its emergence from ...

Purdue Pharma and the Sackler family who controlled it have agreed to pay up to $7.4bn (£6bn) to settle claims regarding its powerful prescription painkiller OxyContin. The deal represents an increase ...

The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths in the US over the past two decades.

Purdue Pharma's earlier settlement plan included a $6 billion contribution from the Sacklers in exchange for immunity from all civil opioid claims.

Members of the Sackler family that owns Purdue Pharma, the maker of OxyContin, and the company have agreed to pay up to $7.4 billion in a new settlement related to lawsuits over the impacts of the ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...